{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:09:59Z","timestamp":1792782599160,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Italian Ministry of Health","award":["RC 2013-2015"],"award-info":[{"award-number":["RC 2013-2015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00210-017-1438-4","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:23:38Z","timestamp":1510791818000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Migraine with prolonged aura: phenotype and treatment"],"prefix":"10.1007","volume":"391","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4356-8109","authenticated-orcid":false,"given":"Michele","family":"Viana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Afridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"issue":"7","key":"1438_CR1","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1212\/WNL.0b013e3182824e66","volume":"80","author":"SK Afridi","year":"2013","unstructured":"Afridi SK, Giffin NJ, Kaube H, Goadsby PJ (2013) A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology 80(7):642\u2013647. \nhttps:\/\/doi.org\/10.1212\/WNL.0b013e3182824e66","journal-title":"Neurology"},{"issue":"9","key":"1438_CR2","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1111\/j.1468-1331.2007.01900.x","volume":"14","author":"V Artto","year":"2007","unstructured":"Artto V, Nissila M, Wessman M et al (2007) Treatment of hemiplegic migraine with triptans. Eur J Neurol 14(9):1053\u20131056. \nhttps:\/\/doi.org\/10.1111\/j.1468-1331.2007.01900.x","journal-title":"Eur J Neurol"},{"issue":"5","key":"1438_CR3","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/ana.410400526","volume":"40","author":"BS Athwal","year":"1996","unstructured":"Athwal BS, Lennox GG (1996) Acetazolamide responsiveness in familial hemiplegic migraine. Ann Neurol 40(5):820\u2013821. \nhttps:\/\/doi.org\/10.1002\/ana.410400526","journal-title":"Ann Neurol"},{"issue":"4","key":"1438_CR4","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/ana.20778","volume":"59","author":"C Ayata","year":"2006","unstructured":"Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA (2006) Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 59(4):652\u2013661. \nhttps:\/\/doi.org\/10.1002\/ana.20778","journal-title":"Ann Neurol"},{"issue":"9","key":"1438_CR5","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1212\/WNL.44.9.1587","volume":"44","author":"D Bates","year":"1994","unstructured":"Bates D, Ashford E, Dawson R, Ensink FBM, Gilhus NE, Olesen J, Pilgrim AJ, Shevlin P, Sumatriptan Aura Study Group (1994) Subcutaneous sumatriptan during the migraine aura. Neurology 44(9):1587\u20131592. \nhttps:\/\/doi.org\/10.1212\/WNL.44.9.1587","journal-title":"Neurology"},{"issue":"1","key":"1438_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1212\/WNL.53.1.38","volume":"53","author":"SS Battistini","year":"1999","unstructured":"Battistini SS, Tenirri S, Piatti M et al (1999) A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology 53(1):38\u201343. \nhttps:\/\/doi.org\/10.1212\/WNL.53.1.38","journal-title":"Neurology"},{"issue":"1","key":"1438_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1046\/j.1526-4610.2000.00010.x","volume":"40","author":"MS Bento","year":"2000","unstructured":"Bento MS, Esperan\u00e7a P (2000) Migraine with prolonged aura. Headache 40(1):52\u201353. \nhttps:\/\/doi.org\/10.1046\/j.1526-4610.2000.00010.x","journal-title":"Headache"},{"issue":"6","key":"1438_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10194-008-0067-1","volume":"9","author":"R Bhatia","year":"2008","unstructured":"Bhatia R, Desai S, Tripathi M, Garg A, Padma MV, Prasad K, Singh MB (2008) Sporadic hemiplegic migraine: report of a case with clinical and radiological features. J Headache Pain 9(6):385\u2013388. \nhttps:\/\/doi.org\/10.1007\/s10194-008-0067-1","journal-title":"J Headache Pain"},{"issue":"2","key":"1438_CR9","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.nbd.2010.10.014","volume":"41","author":"VB Bogdanov","year":"2011","unstructured":"Bogdanov VB, Multon S, Chauvel V, Bogdanova OV, Prodanov D, Makarchuk MY, Schoenen J (2011) Migraine preventive drugs differently affect cortical spreading depression in the rat. Neurobiol Dis 41(2):430\u2013435. \nhttps:\/\/doi.org\/10.1016\/j.nbd.2010.10.014","journal-title":"Neurobiol Dis"},{"key":"1438_CR10","doi-asserted-by":"publisher","unstructured":"Cuadrado ML, Aledo-Serrano A, Lopez-Ruiz P, Gutierrez-Viedma A, Fernandez C, Orviz A, Arias JA (2016) Greater occipital nerve block for the acute treatment of prolonged or persistent migraine aura. Cephalalgia 37(8):812\u2013818. \nhttps:\/\/doi.org\/10.1177\/0333102416655160","DOI":"10.1177\/0333102416655160"},{"key":"1438_CR11","doi-asserted-by":"publisher","unstructured":"De Cunto A, Bensa M, Tonelli A (2012) A case of familial hemiplegic migraine associated with a novel ATP1A2 gene mutation. Pediatr Neurol 47(2):133\u2013136. \nhttps:\/\/doi.org\/10.1016\/j.pediatrneurol.2012.04.012","DOI":"10.1016\/j.pediatrneurol.2012.04.012"},{"issue":"3","key":"1438_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1526-4610.2010.01793.x","volume":"51","author":"Sanctis De","year":"2011","unstructured":"De Sanctis et al (2011) Prolonged sporadic hemiplegic migraine associated with a novel de novo missense ATP1A2 gene mutation. Headache 51(3):447\u2013450. \nhttps:\/\/doi.org\/10.1111\/j.1526-4610.2010.01793.x","journal-title":"Headache"},{"key":"1438_CR13","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","volume":"386","author":"Global Burden of Disease Study 2013 Collaborators","year":"2015","unstructured":"Global Burden of Disease Study 2013 Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386:743\u2013800","journal-title":"Lancet"},{"issue":"10","key":"1438_CR14","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1177\/0333102410368444","volume":"30","author":"JM Hansen","year":"2010","unstructured":"Hansen JM, Hauge AW, Olesen J, Ashina M (2010) CGRP triggers migraine like attacks in patients with migraine with aura. Cephalalgia 30(10):1179\u20131186. \nhttps:\/\/doi.org\/10.1177\/0333102410368444","journal-title":"Cephalalgia"},{"key":"1438_CR15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1474-4422(09)70135-8","volume":"8","author":"AW Hauge","year":"2009","unstructured":"Hauge AW, Asghar MS, Schytz HW, Christensen K, Olesen J (2009) Effects of Tonabersat on migraine with aura: a randomized, double-blind, placebo controlled crossover study. Lancet Neurol 8:718\u2013723","journal-title":"Lancet Neurol"},{"issue":"Suppl 7","key":"1438_CR16","first-page":"1","volume":"8","author":"Headache Classification Committee of The International Headache Society","year":"1988","unstructured":"Headache Classification Committee of The International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl 7):1\u201396","journal-title":"Cephalalgia"},{"issue":"9","key":"1438_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1177\/0333102413485658","volume":"33","author":"Headache Classification Committee of the International Headache Society","year":"2013","unstructured":"Headache Classification Committee of the International Headache Society (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33(9):629\u2013808. \nhttps:\/\/doi.org\/10.1177\/0333102413485658","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"1438_CR18","first-page":"1","volume":"24","author":"Headache Classification Subcommittee of the International Headache Society","year":"2004","unstructured":"Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders (2nd edn). Cephalalgia 24(Suppl 1):1\u2013160","journal-title":"Cephalalgia"},{"key":"1438_CR19","first-page":"958","volume":"18","author":"TW Ho","year":"2014","unstructured":"Ho TW, Connor KM, Zhang Y et al (2014) Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention. Neurology 18:958\u2013966","journal-title":"Neurology"},{"key":"1438_CR20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ana.23653","volume":"72","author":"PR Holland","year":"2012","unstructured":"Holland PR, Akerman S, Andreou AP, Karsan N, Wemmie JA, Goadsby PJ (2012) Acid-sensing ion channel 1: a novel therapeutic target for migraine with aura. Ann Neurol 72:559\u2013563","journal-title":"Ann Neurol"},{"key":"1438_CR21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.braindev.2007.05.013","volume":"30","author":"DA Hsu","year":"2008","unstructured":"Hsu DA, Stafstrom CE, Rowley HA, Kiff JE, Dulli DA (2008) Hemiplegic migraine: hyperperfusion and abortive therapy with intravenous verapamil. Brain Dev 30:86\u201390","journal-title":"Brain Dev"},{"key":"1438_CR22","doi-asserted-by":"publisher","unstructured":"Karsan N, Goadsby PJ (2015) CGRP mechanism antagonists and migraine management. Curr Neurol Neurosci Rep 15(5):25. \nhttps:\/\/doi.org\/10.1007\/s11910-015-0547-z","DOI":"10.1007\/s11910-015-0547-z"},{"key":"1438_CR23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.55.1.139","volume":"55","author":"H Kaube","year":"2000","unstructured":"Kaube H, Herzog J, K\u00e4ufer T, Dichgans M, Diener HC (2000) Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. Neurology 55:139\u2013141","journal-title":"Neurology"},{"issue":"10","key":"1438_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1046\/j.1526-4610.2001.01192.x","volume":"41","author":"J Klapper","year":"2001","unstructured":"Klapper J, Mathew N, Nett R (2001) Triptans in the treatment of basilar migraine and migraine with prolonged aura. Headache 41(10):981\u2013984. \nhttps:\/\/doi.org\/10.1046\/j.1526-4610.2001.01192.x","journal-title":"Headache"},{"issue":"03","key":"1438_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1055\/s-0029-1223464","volume":"37","author":"HJ Koch","year":"2010","unstructured":"Koch HJ, Sykora A, Hausn P (2010) Off-label use of acetazolamide in a patient with familial hemiplegic migraine and concomitant psychotic episodes. Psychiatr Prax 37(03):148\u2013151. \nhttps:\/\/doi.org\/10.1055\/s-0029-1223464","journal-title":"Psychiatr Prax"},{"issue":"5","key":"1438_CR26","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1001\/archneur.60.5.684","volume":"60","author":"E Kors","year":"2003","unstructured":"Kors E (2003) Expanding the phenotypic spectrum of the CACNA1A gene T666M mutation: a description of 5 families with familial hemiplegic migraine. Arch Neurol 60(5):684\u2013688. \nhttps:\/\/doi.org\/10.1001\/archneur.60.5.684","journal-title":"Arch Neurol"},{"issue":"4","key":"1438_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1046\/j.1468-2982.1999.019004241.x","volume":"19","author":"PA Kowacs","year":"1999","unstructured":"Kowacs PA, Piovesan EJ, Tatsui CE, Lange MC, Ribas LC, Werneck LC (1999) Prolonged migraine aura without headache arrested by sumatriptan. A case report with further considerations. Cephalalgia 19(4):241\u2013242. \nhttps:\/\/doi.org\/10.1046\/j.1468-2982.1999.019004241.x","journal-title":"Cephalalgia"},{"issue":"5","key":"1438_CR28","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0022-3476(82)80293-X","volume":"101","author":"CW Lai","year":"1982","unstructured":"Lai CW, Ziegler DK, Lansky LL, Torres F (1982) Hemiplegic migraine in childhood: diagnostic and therapeutic aspects. J Pediatr 101(5):696\u2013699. \nhttps:\/\/doi.org\/10.1016\/S0022-3476(82)80293-X","journal-title":"J Pediatr"},{"issue":"12","key":"1438_CR29","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1136\/jnnp.2005.063750","volume":"76","author":"C Lampl","year":"2005","unstructured":"Lampl C, Katsarava Z, Diener HC, Limmroth V (2005) Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura. J Neurol Neurosurg Psychiatry 76(12):1730\u20131732. \nhttps:\/\/doi.org\/10.1136\/jnnp.2005.063750","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"1438_CR30","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1468-2982.2008.01603.x","volume":"28","author":"A Lebas","year":"2008","unstructured":"Lebas A, Guyant-Marechal L, Hannequin D et al (2008) Severe attacks of familial hemiplegic migraine, childhood epilepsy and ATP1A2 mutation. Cephalalgia 28(7):774\u2013777. \nhttps:\/\/doi.org\/10.1111\/j.1468-2982.2008.01603.x","journal-title":"Cephalalgia"},{"key":"1438_CR31","doi-asserted-by":"crossref","first-page":"e 1002129","DOI":"10.1371\/journal.pgen.1002129","volume":"7","author":"L Leo","year":"2011","unstructured":"Leo L, Gherardini L, Barone V, De Fusco M, Pietrobon D, Pizzorusso T, Casari G (2011) Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2. PLoS Genet 7:e 1002129","journal-title":"PLoS Genet"},{"key":"1438_CR32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/0333102413500727","volume":"34","author":"R Marcus","year":"2014","unstructured":"Marcus R, Goadsby PJ, Dodick D et al (2014) BMS-927711 for the acute treatment of migraine: a double-blind, randomized, placebo controlled, dose-ranging trial. Cephalalgia 34:114\u2013125","journal-title":"Cephalalgia"},{"issue":"3","key":"1438_CR33","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1469-8749.2011.04154.x","volume":"54","author":"BP Mohamed","year":"2012","unstructured":"Mohamed BP, Goadsby PJ, Prabhakar P (2012) Safety and efficacy of flunarizine in childhood migraine: 11 years\u2019 experience, with emphasis on its effect in hemiplegic migraine. Dev Med Child Neurol 54(3):274\u2013277. \nhttps:\/\/doi.org\/10.1111\/j.1469-8749.2011.04154.x","journal-title":"Dev Med Child Neurol"},{"issue":"10","key":"1438_CR34","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1468-1331.2004.00914.x","volume":"11","author":"J Olesen","year":"2004","unstructured":"Olesen J, Diener HC, Schoenen J, Hettiarachchi J (2004) No effect of eletriptan administration during the aura phase of migraine. Eur J Neurol 11(10):671\u2013677. \nhttps:\/\/doi.org\/10.1111\/j.1468-1331.2004.00914.x","journal-title":"Eur J Neurol"},{"issue":"4","key":"1438_CR35","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.braindev.2010.05.006","volume":"33","author":"T Omata","year":"2011","unstructured":"Omata T, Takanashi J, Wada T et al (2011) Genetic diagnosis and acetazolamide treatment of familial hemiplegic migraine. Brain and Development 33(4):332\u2013334. \nhttps:\/\/doi.org\/10.1016\/j.braindev.2010.05.006","journal-title":"Brain and Development"},{"issue":"10","key":"1438_CR36","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/j.1526-4610.2004.04198.x","volume":"44","author":"J Pascual","year":"2004","unstructured":"Pascual J, Caminero AB, Mateos V, Roig C, Leira R, Garcia-Monco C, Lainez MJ (2004) Preventing disturbing migraine aura with lamotrigine: an open study. Headache 44(10):1024\u20131028. \nhttps:\/\/doi.org\/10.1111\/j.1526-4610.2004.04198.x","journal-title":"Headache"},{"issue":"9","key":"1438_CR37","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/0333102413520086","volume":"34","author":"N Pelzer","year":"2014","unstructured":"Pelzer N, Stam AH, Carpay JA, Vries BD, van den Maagdenberg AM et al (2014) Familial hemiplegic migraine treated by sodium valproate and lamotrigine. Cephalalgia 34(9):708\u2013711. \nhttps:\/\/doi.org\/10.1177\/0333102413520086","journal-title":"Cephalalgia"},{"issue":"6","key":"1438_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1046\/j.1468-2982.1991.1106257.x","volume":"11","author":"V Pfaffenrath","year":"1991","unstructured":"Pfaffenrath V, Kommissari I, P\u00f6llmann W, Kaube H, Rath M (1991) Cerebrovascular risk factors in migraine with prolonged aura and without aura. Cephalalgia 11(6):257\u2013261. \nhttps:\/\/doi.org\/10.1046\/j.1468-2982.1991.1106257.x","journal-title":"Cephalalgia"},{"issue":"3","key":"1438_CR39","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1177\/0333102413500729","volume":"34","author":"S Pye","year":"2014","unstructured":"Pye S, Ahmed M (2014) Duration of migraine aura. Cephalalgia 34(3):236. \nhttps:\/\/doi.org\/10.1177\/0333102413500729","journal-title":"Cephalalgia"},{"issue":"1-2","key":"1438_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/0006-8993(95)00692-J","volume":"693","author":"A Rashidy-Pour","year":"1995","unstructured":"Rashidy-Pour A, Motaghed-Larijani Z, Bures J (1995) Tolerance to ketamine-induced blockade of cortical spreading depression transfers to MK-801 but not to AP5 in rats. Brain Res 693(1-2):64\u201369. \nhttps:\/\/doi.org\/10.1016\/0006-8993(95)00692-J","journal-title":"Brain Res"},{"issue":"1","key":"1438_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1212\/WNL.48.1.261","volume":"48","author":"JF Rothrock","year":"1997","unstructured":"Rothrock JF (1997) Successful treatment of persistent migraine aura with divalproex sodium. Neurology 48(1):261\u2013262. \nhttps:\/\/doi.org\/10.1212\/WNL.48.1.261","journal-title":"Neurology"},{"issue":"8","key":"1438_CR42","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1046\/j.1526-4610.2003.03170.x","volume":"43","author":"T Rozen","year":"2003","unstructured":"Rozen T (2003) Aborting a prolonged migrainous aura with intravenous prochlorperazine and magnesium sulphate. Headache 43(8):901\u2013903. \nhttps:\/\/doi.org\/10.1046\/j.1526-4610.2003.03170.x","journal-title":"Headache"},{"issue":"7","key":"1438_CR43","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1526-4610.2004.04126.x","volume":"44","author":"TD Rozen","year":"2004","unstructured":"Rozen TD, Shanske S, Otaegui D, Lu J, Young WB, Bradley K, DiMauro S, Silberstein SD (2004) Study of mitochondrial DNA mutations in patients with migraine with prolonged aura. Headache 44(7):674\u2013677. \nhttps:\/\/doi.org\/10.1111\/j.1526-4610.2004.04126.x","journal-title":"Headache"},{"issue":"5","key":"1438_CR44","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1474-4422(11)70048-5","volume":"10","author":"MB Russel","year":"2011","unstructured":"Russel MB, Ducros A (2011) Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 10(5):457\u2013470. \nhttps:\/\/doi.org\/10.1016\/S1474-4422(11)70048-5","journal-title":"Lancet Neurol"},{"key":"1438_CR45","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1007\/s10194-009-0181-8","volume":"11","author":"VB Silva","year":"2010","unstructured":"Silva VB, In\u00e0cio N, Simoes R et al (2010) Prolonged migraine auras. J Headache Pain 11:S79","journal-title":"J Headache Pain"},{"issue":"2","key":"1438_CR46","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1046\/j.1468-2982.1997.1702109.x","volume":"17","author":"TJ Steiner","year":"1997","unstructured":"Steiner TJ, Findley LJ, Yuen AW (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17(2):109\u2013112. \nhttps:\/\/doi.org\/10.1046\/j.1468-2982.1997.1702109.x","journal-title":"Cephalalgia"},{"issue":"12","key":"1438_CR47","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/j.1468-2982.2004.00788.x","volume":"24","author":"LL Thomsen","year":"2004","unstructured":"Thomsen LL, Olesen J (2004) Sporadic hemiplegic migraine. Cephalalgia 24(12):1016\u20131024. \nhttps:\/\/doi.org\/10.1111\/j.1468-2982.2004.00788.x","journal-title":"Cephalalgia"},{"issue":"9","key":"1438_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/j.1526-4610.1987.hed2709487.x","volume":"27","author":"M Tobita","year":"1987","unstructured":"Tobita M, Hino M, Ichikawa N, Takase S, Ogawa A (1987) A case of hemiplegic migraine treated with flunarizine. Headache 27(9):487\u2013488. \nhttps:\/\/doi.org\/10.1111\/j.1526-4610.1987.hed2709487.x","journal-title":"Headache"},{"issue":"1","key":"1438_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ana.21815","volume":"67","author":"Maagdenberg Van den","year":"2010","unstructured":"Van den Maagdenberg, Pizzorusso T, Kaja S, Terpolilli N, Shapovalova M et al (2010) High cortical spreading depression susceptibility and migraine associated symptoms in Cav2.1 S218L mice. Ann Neurol 67(1):85\u201398. \nhttps:\/\/doi.org\/10.1002\/ana.21815","journal-title":"Ann Neurol"},{"issue":"7","key":"1438_CR50","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1177\/0333102413479834","volume":"33","author":"M Viana","year":"2013","unstructured":"Viana M, Sprenger T, Andelova M, Goadsby PJ (2013) The typical duration of migraine aura: a systematic review. Cephalalgia 33(7):483\u2013490. \nhttps:\/\/doi.org\/10.1177\/0333102413479834","journal-title":"Cephalalgia"},{"key":"1438_CR51","doi-asserted-by":"publisher","unstructured":"Viana M, Linde M, Sances G, Ghiotto N, Guaschino E, Allena M, Terrazzino S, Nappi G, Goadsby PJ, Tassorelli C (2015) O011. Patients with \u201cprolonged aura\u201d do not show clinical or demographic differences from the patients with \u201ctypical aura\u201d. J Headache Pain 16(Suppl 1):A67. \nhttps:\/\/doi.org\/10.1186\/1129-2377-16-S1-A67","DOI":"10.1186\/1129-2377-16-S1-A67"},{"issue":"9","key":"1438_CR52","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1177\/0333102415613612","volume":"36","author":"M Viana","year":"2016","unstructured":"Viana M, Sances G, Ghiotto N, Guaschino E, Allena M, Nappi G, Goadsby PJ, Tassorelli C (2016a) Variability of the characteristics of a migraine attack within patients. Cephalalgia 36(9):825\u2013830. \nhttps:\/\/doi.org\/10.1177\/0333102415613612","journal-title":"Cephalalgia"},{"issue":"5","key":"1438_CR53","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/0333102415593089","volume":"36","author":"M Viana","year":"2016","unstructured":"Viana M, Linde M, Sances G, Ghiotto N, Guaschino E, Allena M, Nappi G, Goadsby PJ, Tassorelli C (2016b) Migraine aura symptoms: duration, succession and temporal relationship to headache. Cephalalgia 36(5):413\u2013421. \nhttps:\/\/doi.org\/10.1177\/0333102415593089","journal-title":"Cephalalgia"},{"issue":"10","key":"1438_CR54","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1177\/0333102416657147","volume":"37","author":"M Viana","year":"2017","unstructured":"Viana M, Sances G, Linde M, Ghiotto N, Guaschino E, Allena M, Terrazzino S, Nappi G, Goadsby PJ, Tassorelli C (2017a) Clinical features of migraine aura: results from a prospective diary-aided study. Cephalalgia 37(10):979\u2013989. \nhttps:\/\/doi.org\/10.1177\/0333102416657147","journal-title":"Cephalalgia"},{"key":"1438_CR55","doi-asserted-by":"publisher","unstructured":"Viana M, Sances G, Linde M, Nappi G, Goadsby PJ, Tassorelli C (2017b) EP-02-024 Prolonged migraine aura: new insights from a prospective diary-aided study. Cephalalgia 37(Suppl 1):189.\u00a0\nhttps:\/\/doi.org\/10.1177\/0333102417719574","DOI":"10.1177\/0333102417719574"},{"key":"1438_CR56","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/0333102416653233","volume":"36","author":"T Voss","year":"2016","unstructured":"Voss T, Lipton RB, Dodick DW et al (2016) A phase IIb randomized, doubleblind, placebo-controlled trial of ubrogepant for the acute treatment of migraine. Cephalalgia 36:887\u2013898","journal-title":"Cephalalgia"},{"key":"1438_CR57","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/0006-8993(94)91234-3","volume":"637","author":"M Wahl","year":"1994","unstructured":"Wahl M, Schilling L, Parsons AA, Kaumann A (1994) Involvement of CGRP and NO in the pial artery dilatation elicited by cortical spreading depression. Brain Res 637:2004\u20132010","journal-title":"Brain Res"},{"issue":"9","key":"1438_CR58","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1212\/WNL.57.9.1732","volume":"57","author":"W Yu","year":"2001","unstructured":"Yu W, Horowitz SH (2001) Familial hemiplegic migraine and its abortive therapy with intravenous verapamil. Neurology 57(9):1732\u20131733. \nhttps:\/\/doi.org\/10.1212\/WNL.57.9.1732","journal-title":"Neurology"},{"issue":"1","key":"1438_CR59","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1212\/01.WNL.0000042051.16284.70","volume":"60","author":"W Yu","year":"2003","unstructured":"Yu W, Horowitz SH (2003) Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil. Neurology 60(1):120\u2013121. \nhttps:\/\/doi.org\/10.1212\/01.WNL.0000042051.16284.70","journal-title":"Neurology"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-017-1438-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1438-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-017-1438-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T17:05:43Z","timestamp":1514826343000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-017-1438-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,16]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["1438"],"URL":"https:\/\/doi.org\/10.1007\/s00210-017-1438-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,16]]}}}